Nanoparticle formulation of ormeloxifene for pancreatic cancer

Pancreatic cancer is the fourth most prevalent cancer with about an 85% mortality rate; thus, an utmost need exists to discover new therapeutic modalities that would enhance therapy outcomes of this disease with minimal or no side effects. Ormeloxifene (ORM), a synthetic molecule, has exhibited pote...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Biomaterials
Päätekijät: Khan, Sheema, Chauhan, Neeraj, Yallapu, Murali M., Ebeling, Mara C., Balakrishna, Swathi, Ellis, Robert T., Thompson, Paul A., Balabathula, Pavan, Behrman, Stephen W., Zafar, Nadeem, Singh, Man Mohan, Halaweish, Fathi T., Jaggi, Meena, Chauhan, Subhash C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4405677/
https://ncbi.nlm.nih.gov/pubmed/25890768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2015.02.082
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia